Shaalan Beg, Senior Advisor for Clinical Research at the National Cancer Institute (NCI) and Chief Medical Officer at ConcertAI, shared a post by Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, adding:
“This is such an important study to evaluate the role of novel radiation methods for locally advanced pancreatic cancer.
If you don’t have this trial open at your institution then what are you even doing?”
Quoting Nina Niu Sanford‘s post:
“Quick update on NRG-GI011 (LAP100) pancreas cancer RCT: accrual status, recent amendment, etc. Hope this is helpful & appreciate the support for our trial.”